Supporting this hypothesis, male aromatase knockout mice have increased adiposity (9), hepatic steatosis (10), and insulin resistance (11), with similar features observed in rare cases of human aromatase deficiency (12); in both cases, estrogen replacement largely reverses the abnormal phenotype. The gene discussed is CYP19A1; the disease is Insulin resistance.